Detalhe da pesquisa
1.
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial.
Lancet Microbe
; 3(4): e252-e264, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35287430